OBJECTIVE: To address the incidence of varicella-zoster virus (VZV) infection in patients with biopsy-negative giant cell arteritis (GCA), we examined archived biopsy-negative temporal arteries from subjects with clinically suspected GCA for the presence of VZV antigen. METHODS: Formalin-fixed, paraffin-embedded temporal arteries that were pathologically negative for GCA and normal temporal arteries were analyzed immunohistochemically for VZV and herpes simplex virus-1 (HSV-1) antigen. RESULTS: Five (21%) of 24 temporal arteries from patients who were clinically suspect but biopsy negative for GCA revealed VZV but not HSV-1 by immunohistochemical analysis. Thirteen normal temporal arteries did not contain VZV or HSV-1 antigen. All 5 subjects whose temporal arteries contained VZV antigen presented with clinical and laboratory features of GCA and early visual disturbances. CONCLUSION: Multifocal VZV vasculopathy can present with the full spectrum of clinical features and laboratory abnormalities characteristically seen in GCA.
OBJECTIVE: To address the incidence of varicella-zoster virus (VZV) infection in patients with biopsy-negative giant cell arteritis (GCA), we examined archived biopsy-negative temporal arteries from subjects with clinically suspected GCA for the presence of VZV antigen. METHODS:Formalin-fixed, paraffin-embedded temporal arteries that were pathologically negative for GCA and normal temporal arteries were analyzed immunohistochemically for VZV and herpes simplex virus-1 (HSV-1) antigen. RESULTS: Five (21%) of 24 temporal arteries from patients who were clinically suspect but biopsy negative for GCA revealed VZV but not HSV-1 by immunohistochemical analysis. Thirteen normal temporal arteries did not contain VZV or HSV-1 antigen. All 5 subjects whose temporal arteries contained VZV antigen presented with clinical and laboratory features of GCA and early visual disturbances. CONCLUSION: Multifocal VZV vasculopathy can present with the full spectrum of clinical features and laboratory abnormalities characteristically seen in GCA.
Authors: M A Nagel; I Traktinskiy; Y Azarkh; B Kleinschmidt-DeMasters; T Hedley-Whyte; A Russman; E M VanEgmond; K Stenmark; M Frid; R Mahalingam; M Wellish; A Choe; R Cordery-Cotter; R J Cohrs; D Gilden Journal: Neurology Date: 2011-07-13 Impact factor: 9.910
Authors: C Nordborg; E Nordborg; V Petursdottir; J LaGuardia; R Mahalingam; M Wellish; D H Gilden Journal: Ann Neurol Date: 1998-09 Impact factor: 10.422
Authors: Maria A Nagel; Andrew N Russman; Howard Feit; Igor Traktinskiy; Nelly Khmeleva; D Scott Schmid; Barry Skarf; Don Gilden Journal: Neurology Date: 2012-12-19 Impact factor: 9.910
Authors: Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden Journal: Arch Neurol Date: 2011-04
Authors: Brian Silver; Maria A Nagel; Ravi Mahalingam; Randall Cohrs; D Scott Schmid; Don Gilden Journal: J Neurol Sci Date: 2012-08-27 Impact factor: 3.181
Authors: Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden Journal: Neurology Date: 2012-12-12 Impact factor: 9.910
Authors: Marc Mathias; Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Vikram D Durairaj; Jeffrey L Bennett; Naresh Mandava; Don Gilden Journal: J Neurol Sci Date: 2013-01-11 Impact factor: 3.181
Authors: Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Robert Bert; Don Gilden Journal: J Neurol Sci Date: 2013-10-02 Impact factor: 3.181
Authors: Tiago Teodoro; Maria A Nagel; Ruth Geraldes; Teresa White; Ravi Mahalingam; Paulo Batista; Mary Wellish; Jose Pimentel; Nelly Khmeleva; Anna Heintzman; Luísa Albuquerque; Philip J Boyer; Alexander Choe; Rita Peralta; Don Gilden Journal: J Neurol Sci Date: 2014-05-27 Impact factor: 3.181